Answer: Monoclonal antibodies.
- A Transgenic plants
- B Monoclonal antibodies
- C Recombinant insulin
- D PCR products
Correct answer: B. Monoclonal antibodies
Explanation: Hybridoma technology fuses antibody-producing B cells with cancer cells (myeloma) to create immortal hybridomas that produce monoclonal antibodies.
Recombinant DNA technology: a gene of interest and plasmid are cut by the same restriction enzyme, ligated into a recombinant plasmid, and introduced into a host cell.
Concept context
Recombinant DNA, GMOs, PCR, CRISPR, and biotechnology applications. Growing importance in NEET.
Read the full Biotechnology: Principles and Processes notes →